Kim Kelderman

2018

In 2018, Kim Kelderman earned a total compensation of $1.2M as President, Diagnostics and Genomics at Bio-Techne.

Compensation breakdown

Non-Equity Incentive Plan$36,250
Option Awards$301,603
Salary$72,500
Stock Awards$753,900
Other$1,004
Total$1,165,256

Kelderman received $753.9K in stock awards, accounting for 65% of the total pay in 2018.

Kelderman also received $36.3K in non-equity incentive plan, $301.6K in option awards, $72.5K in salary and $1K in other compensation.

Rankings

In 2018, Kim Kelderman's compensation ranked 8,421st out of 14,244 executives tracked by ExecPay. In other words, Kelderman earned more than 40.9% of executives.

ClassificationRankingPercentile
All
8,421
out of 14,244
41st
Division
Manufacturing
3,345
out of 5,765
42nd
Major group
Chemicals And Allied Products
1,255
out of 2,128
41st
Industry group
Drugs
1,048
out of 1,817
42nd
Industry
Biological Products, Except Diagnostic Substances
197
out of 339
42nd
Source: SEC filing on September 9, 2019.

Kelderman's colleagues

We found four more compensation records of executives who worked with Kim Kelderman at Bio-Techne in 2018.

2018

Charles Kummeth

Bio-Techne

Chief Executive Officer

2018

James Hippel

Bio-Techne

Chief Financial Officer

2018

David Eansor

Bio-Techne

Senior Vice President Biotechnology

2018

Brenda Furlow

Bio-Techne

General Counsel

News

You may also like